Market Overview The viral vectors and plasmid DNA manufacturing market is increasingly reliant on contract manufacturing and outsourcing as gene therapy companies, particularly small biotechnology firms with limited capital, choose to access specialized production expertise rather than building internal manufacturing infrastructure. Viral vector and plasmid production require unique facilities,...